Michael J. McElhaugh

Insider Reports History

Location
Doylestown, PA
Signature
/s/ David C. Hastings as attorney-in-fact for Michael J. McElhaugh
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael J. McElhaugh:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arbutus Biopharma Corp Interim President & CEO, Director Common Shares 1,658,003 $5,443,224 $3.28 14 Feb 2025 Direct
Arbutus Biopharma Corp Interim President & CEO, Director Stock Option (Right to Buy) 718,800 14 Feb 2025 Direct

Insider Reports Filed by Michael J. McElhaugh

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ABUS Arbutus Biopharma Corp 14 Feb 2025 2 $0 4 Interim President & CEO, Director 19 Feb 2025, 18:25
ABUS Arbutus Biopharma Corp 04 Feb 2025 1 -$78,103 4 Interim President & CEO, Director 05 Feb 2025, 16:02
ABUS Arbutus Biopharma Corp 01 Feb 2024 3 -$23,504 4 Interim President & CEO, Director 05 Feb 2024, 19:54
ABUS Arbutus Biopharma Corp 01 Feb 2023 2 $0 4 Chief Business Officer 03 Feb 2023, 15:12
ABUS Arbutus Biopharma Corp 20 Jan 2022 1 +$915,638 4 Chief Business Officer 20 Jan 2022, 16:53